An Improved Method for Generating Retroviral Producer Clones for Vectors Lacking a Selectable Marker Gene

Author： Persons D.A.   Mehaffey M.G.   Kaleko M.   Nienhuis A.W.   Nienhuis E.A.F.W.  

Publisher： Academic Press

ISSN： 1079-9796

Source： Blood Cells, Molecules, and Diseases, Vol.24, Iss.2, 1998-06, pp. : 167-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy-based Approaches to the Treatment of Cancer: Development of Targetable Retroviral Vectors

By Dougherty G.J.   Peters C.E.   Dougherty S.T.   McBride W.H.   Chaplin D.J.  

Transfusion and Apheresis Science, Vol. 17, Iss. 1, 1996-03 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Gene Therapy-based Approaches to the Treatment of Cancer: Development of Targetable Retroviral Vectors

By Dougherty G.J.   Peters C.E.   Dougherty S.T.   McBride W.H.   Chaplin D.J.  

Transfusion Science, Vol. 17, Iss. 1, 1996-03 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Retroviral Vectors

By Hawley R.G.  

Transfusion Science, Vol. 17, Iss. 1, 1996-03 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Retroviral Vectors

By Hawley R.G.  

Transfusion and Apheresis Science, Vol. 17, Iss. 1, 1996-03 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite

Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit - implications for using the MDR 1 gene as a dominant selectable marker

By Jin L.   Neff T.   Blau C.A.  

Experimental Hematology, Vol. 27, Iss. 3, 1999-03 ,pp. : 520-525

Elsevier

Access to resources Recommend Favorite